• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有 CD44 靶向和 ROS 触发特性的纳米颗粒作为有效的体内抗原递呈系统。

Nanoparticles with CD44 Targeting and ROS Triggering Properties as Effective in Vivo Antigen Delivery System.

机构信息

Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College , Tianjin 300192, China.

Key Laboratory of Bioactive Materials, Ministry of Education, Nankai University , Tianjin 300071, China.

出版信息

Mol Pharm. 2018 Feb 5;15(2):508-518. doi: 10.1021/acs.molpharmaceut.7b00890. Epub 2018 Jan 25.

DOI:10.1021/acs.molpharmaceut.7b00890
PMID:29323913
Abstract

Currently, development of subunit vaccine based on recombinant antigens or peptides has gradually become an important alternative option for traditional vaccine. However, induction of potent immune response with desired efficacy remains a major challenge. The nanoparticle-based antigen delivery system has been considered a potential carrier system to improve the efficacy of subunit vaccine. In the present study, we have designed an immune-stimulatory delivery system by conjugating three-armed PLGA to PEG via the peroxalate ester bond which is sensitive to hydrogen peroxide (HO), a major reactive oxygen species (ROS). Hyaluronic acid (HA), a ligand for CD44 receptors was also modified onto the outer shell of the 3s-PLGA-PEG nanoparticles to promote immune cell uptake. For in vitro and in vivo immune response assessment, a model antigen ovalbumin (OVA) was enclosed within the core of the 3s-PLGA-PEG nanoparticles to form 3s-PLGA-PO-PEG/HA nanoparticles (PHO NPs). Our results showed that the PHO NPs enhanced dendritic cell maturation, antigen uptake, and antigen presentation in vitro, likely due to enhanced lysosomal escape. In vivo experiments further revealed that the PHO nanovaccine robustly promoted OVA-specific antibody production and T cell response accompanied by modest stimulation of memory T cells. In summary, the ROS-responsive PHO NPs with modified HA may be an effective vehicle antigen delivery system to promote antigen-induced immune response.

摘要

目前,基于重组抗原或肽的亚单位疫苗的开发已逐渐成为传统疫苗的重要替代方案。然而,诱导具有所需疗效的强烈免疫反应仍然是一个主要挑战。基于纳米颗粒的抗原递药系统已被认为是提高亚单位疫苗疗效的潜在载体系统。在本研究中,我们通过过氧酯键将三臂 PLGA 偶联到 PEG 上,设计了一种免疫刺激性递药系统,而过氧酯键对过氧化氢(HO)敏感,HO 是主要的活性氧(ROS)之一。透明质酸(HA),一种 CD44 受体的配体,也被修饰到 3s-PLGA-PEG 纳米颗粒的外壳上,以促进免疫细胞摄取。为了评估体外和体内免疫反应,我们将模型抗原卵清蛋白(OVA)包裹在 3s-PLGA-PEG 纳米颗粒的核心内,形成 3s-PLGA-PO-PEG/HA 纳米颗粒(PHO NPs)。我们的结果表明,PHO NPs 增强了树突状细胞的成熟、抗原摄取和抗原呈递,这可能是由于溶酶体逃逸增强所致。体内实验进一步表明,PHO 纳米疫苗可强力促进 OVA 特异性抗体产生和 T 细胞反应,并适度刺激记忆 T 细胞。总之,具有修饰的 HA 的 ROS 响应性 PHO NPs 可能是一种有效的载体抗原递药系统,可促进抗原诱导的免疫反应。

相似文献

1
Nanoparticles with CD44 Targeting and ROS Triggering Properties as Effective in Vivo Antigen Delivery System.具有 CD44 靶向和 ROS 触发特性的纳米颗粒作为有效的体内抗原递呈系统。
Mol Pharm. 2018 Feb 5;15(2):508-518. doi: 10.1021/acs.molpharmaceut.7b00890. Epub 2018 Jan 25.
2
Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.通过一种基于 ROS 触发的纳米颗粒的抗原传递系统提高疫苗诱导的免疫应答。
Nanoscale. 2018 May 24;10(20):9489-9503. doi: 10.1039/c8nr00355f.
3
Cell Penetrating Peptide-Based Redox-Sensitive Vaccine Delivery System for Subcutaneous Vaccination.基于细胞穿透肽的氧化还原敏感疫苗递释系统用于皮下免疫接种。
Mol Pharm. 2018 Mar 5;15(3):975-984. doi: 10.1021/acs.molpharmaceut.7b00905. Epub 2018 Feb 1.
4
Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.用于外源抗原交叉呈递和增强细胞毒性T淋巴细胞免疫反应的聚合物纳米颗粒。
Int J Nanomedicine. 2016 Aug 5;11:3753-64. doi: 10.2147/IJN.S110796. eCollection 2016.
5
Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses.透明质酸修饰的阳离子脂质-PLGA 杂化纳米颗粒作为一种纳米疫苗可诱导强烈的体液和细胞免疫应答。
ACS Appl Mater Interfaces. 2016 May 18;8(19):11969-79. doi: 10.1021/acsami.6b01135. Epub 2016 May 4.
6
Functional characterization of biodegradable nanoparticles as antigen delivery system.可生物降解纳米颗粒作为抗原递送系统的功能表征
J Exp Clin Cancer Res. 2015 Oct 6;34:114. doi: 10.1186/s13046-015-0231-9.
7
pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.具有快速抗原释放行为的 pH 响应性聚(D,L-丙交酯-共-乙交酯)纳米粒子促进免疫反应。
ACS Nano. 2015 May 26;9(5):4925-38. doi: 10.1021/nn5066793. Epub 2015 Apr 24.
8
Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.经毛囊无创递呈纳米颗粒:经皮免疫的新视角。
Vaccine. 2013 Jul 25;31(34):3442-51. doi: 10.1016/j.vaccine.2012.12.048. Epub 2013 Jan 2.
9
Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.通过亲水性聚乙二醇-聚丙交酯-乙交酯-聚丙交酯纳米颗粒递送抗原可增强疫苗接种诱导的T细胞免疫。
Eur J Pharm Biopharm. 2016 May;102:20-31. doi: 10.1016/j.ejpb.2016.02.014. Epub 2016 Mar 2.
10
Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.通过功能化海藻酸钠纳米粒靶向递送至树突状细胞用于癌症免疫治疗。
J Control Release. 2017 Jun 28;256:170-181. doi: 10.1016/j.jconrel.2017.04.020. Epub 2017 Apr 13.

引用本文的文献

1
Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies.肿瘤微环境:理解方面的最新进展及其在调节癌症治疗中的作用
Med Oncol. 2025 Mar 18;42(4):117. doi: 10.1007/s12032-025-02641-4.
2
Research progress of nanovaccine in anti-tumor immunotherapy.纳米疫苗在抗肿瘤免疫治疗中的研究进展
Front Oncol. 2023 Aug 24;13:1211262. doi: 10.3389/fonc.2023.1211262. eCollection 2023.
3
Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review.新兴纳米疗法重塑肝纤维化微环境:全面综述。
J Nanobiotechnology. 2023 Apr 7;21(1):121. doi: 10.1186/s12951-023-01876-5.
4
Highly sensitive HO-scavenging nano-bionic system for precise treatment of atherosclerosis.用于精准治疗动脉粥样硬化的高灵敏度清除羟基自由基纳米仿生系统。
Acta Pharm Sin B. 2023 Jan;13(1):372-389. doi: 10.1016/j.apsb.2022.04.002. Epub 2022 Apr 11.
5
The Immunogenicity of DENV1-4 ED3s Strongly Differ despite Their Almost Identical Three-Dimensional Structures and High Sequence Similarities.登革病毒 1-4 型 ED3 区的免疫原性存在显著差异,尽管它们的三维结构几乎相同,且序列高度相似。
Int J Mol Sci. 2023 Jan 25;24(3):2393. doi: 10.3390/ijms24032393.
6
Locoregional Lymphatic Delivery Systems Using Nanoparticles and Hydrogels for Anticancer Immunotherapy.使用纳米颗粒和水凝胶的局部区域淋巴递送系统用于抗癌免疫治疗
Pharmaceutics. 2022 Dec 8;14(12):2752. doi: 10.3390/pharmaceutics14122752.
7
Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles.基于负载于聚合物纳米颗粒上的透明质酸-CD44相互作用抑制剂的选择性抗癌疗法。
Pharmaceutics. 2022 Apr 4;14(4):788. doi: 10.3390/pharmaceutics14040788.
8
Innovations in lymph node targeting nanocarriers.淋巴靶向纳米载体的创新。
Semin Immunol. 2021 Aug;56:101534. doi: 10.1016/j.smim.2021.101534. Epub 2021 Nov 24.
9
Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy.肿瘤微环境响应型纳米医学用于增强癌症免疫治疗。
Adv Sci (Weinh). 2022 Jan;9(1):e2103836. doi: 10.1002/advs.202103836. Epub 2021 Nov 19.
10
Intelligent stimuli-responsive nano immunomodulators for cancer immunotherapy.用于癌症免疫治疗的智能刺激响应纳米免疫调节剂
Chem Sci. 2021 Feb 10;12(9):3130-3145. doi: 10.1039/d0sc06557a.